Zepbound is made by drugmaker Eli Lilly. While Hims & Hers offers it for $1,899 per month, Lilly said the price on its own ...
Eli Lilly quickly disassociated itself from Hims & Hers after the telehealth company said it was selling the pharmaceutical ...
Eli Lilly (LLY) is targeting additional drug compounders and telehealth companies that make copycat versions of its weight loss drug, with ...
Eli Lilly is broadening its direct-to-consumer approach by partnering with a digital health company, Noom, which is focused ...
Meanwhile, the first major obesity-related phase 3 trial for orforglipron is set to complete in July. If the data from the ...
This integration evolves Noom’s comprehensive approach to weight management by enabling a streamlined solution for members ...
Lately, however, Eli Lilly's stock has cooled. Shares have been essentially flat since July 2024. The market for GLP-1 ...
Telehealth firm Hims & Hers Health said on Tuesday it plans to sell Eli Lilly's diabetes and weight-loss drugs on its ...
Telehealth firm Hims & Hers Health said on Tuesday it plans to sell Eli Lilly's weight-loss drug, as it widens its offerings ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback